Chronic migraine. Chronic migraine without aura
Conditions
Interventions
Intervention 1: Intervention group: Patients in the intervention group will receive levetiracetam tablets, initially 250 mg every 12 hours in the first week, then increased to 500 mg every 12 hours fr
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with chronic migraine Age over 18 years old
Exclusion criteria
Exclusion criteria: Pregnant women Secondary headaches Renal or hepatic dysfunction Severe psychiatric disorders Malignancies Drug or alcohol use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of attacks. Timepoint: Before and 12 weeks after the intervention. Method of measurement: Interview.;Severity of attacks. Timepoint: Before and 12 weeks after the intervention. Method of measurement: HIT6 questionnaire.;Duration of attacks. Timepoint: Before and 12 weeks after the intervention. Method of measurement: Interview. | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications (Dizziness, drowsiness). Timepoint: 12 weeks after intervention. Method of measurement: Interview. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Surena Nazarbaghi
Oroumia University of Medical Sciences
Outcome results
None listed